Validation of high-sensitivity performance for a United States Food and Drug Administration cleared cardiac troponin I assay
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 56, 4-10
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort studyBMJ, 2012
- Reference Limits for N-Terminal-pro-B-Type Natriuretic Peptide in Healthy Individuals (from the Framingham Heart Study)The American Journal of Cardiology, 2011
- Rapid Exclusion of Acute Myocardial Infarction in Patients With Undetectable Troponin Using a High-Sensitivity AssayJACC, 2011
- Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities StudyCirculation, 2011
- Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary SyndromeJAMA, 2011
- Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older AdultsJAMA, 2010
- Universal Definition of Myocardial InfarctionJACC, 2007
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary SyndromesCirculation, 2007
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000
- A new distribution-free quantile estimatorBiometrika, 1982